-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Biomarin Pharmaceutical Inc quarterly/annual Amortization of Intangible Assets history and growth rate from 2023 to 2024.
- Biomarin Pharmaceutical Inc Amortization of Intangible Assets for the quarter ending March 31, 2024 was $14.3 M, a 8.76% decline year-over-year.
- Biomarin Pharmaceutical Inc annual Amortization of Intangible Assets for 2014 was $10.5 M.
- Biomarin Pharmaceutical Inc annual Amortization of Intangible Assets for 2012 was $6.8 M, a 1260% increase from 2011.